Wedbush analyst Yun Zhong initiated coverage of Protagonist Therapeutics (PTGX) with an Outperform rating and $58 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTGX:
- PTGX Upcoming Earnings Report: What to Expect?
- Protagonist Therapeutics participates in a conference call with JPMorgan
- Walmart upgraded, Starbucks downgraded: Wall Street’s top analyst calls
- Protagonist Therapeutics initiated with a Buy at TD Cowen
- Protagonist Therapeutics Board and Audit Committee Changes